PSTX
Closed
Poseida Therapeutics Inc
9.5
0.0 (0.00%)
Last Update: 08 Jan 2025 17:30:00
Yesterday: 9.5
Day's Range: 9.5 - 9.5
Send
sign up or login to leave a comment!
When Written:
2.725
Poseida Therapeutics Inc is a clinical-stage biotechnology company that focuses on developing gene therapies for various diseases. The company uses its proprietary gene engineering platform, called the PiggyBac DNA Modification System, to develop therapies for cancer, genetic diseases, and autoimmune disorders. Poseida's lead product candidate is P-BCMA-101, a CAR-T therapy for the treatment of multiple myeloma. The company also has several other product candidates in preclinical development, including gene therapies for solid tumors and genetic diseases. Poseida Therapeutics was founded in 2015 and is headquartered in San Diego, California.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
sign up or login to leave a comment!!








